🇺🇸 HPV vaccine in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Headache — 3 reports (13.04%)
  2. Pyrexia — 3 reports (13.04%)
  3. Seizure — 3 reports (13.04%)
  4. Convulsion — 2 reports (8.7%)
  5. Dizziness — 2 reports (8.7%)
  6. Drug Effective For Unapproved Indication — 2 reports (8.7%)
  7. Fatigue — 2 reports (8.7%)
  8. Hypertension — 2 reports (8.7%)
  9. Malaise — 2 reports (8.7%)
  10. Off Label Use — 2 reports (8.7%)

Source database →

HPV vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is HPV vaccine approved in United States?

HPV vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for HPV vaccine in United States?

Fondazione IRCCS Policlinico San Matteo di Pavia is the originator. The local marketing authorisation holder may differ — check the official source linked above.